---
title: "Kalohexis confidentially files IPO to back obesity and cachexia portfolio"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292066714.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-08T10:40:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292066714.md)
  - [en](https://longbridge.com/en/news/292066714.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292066714.md)
generator: "portal-rs"
---

# Kalohexis confidentially files IPO to back obesity and cachexia portfolio

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

## Related News & Research

- [Kynexis pockets €97m to advance cognition-focused schizophrenia drug](https://longbridge.com/en/news/296501085.md)
- [Enrolment concludes in Lynch’s Phase II rhPDGF-BB study](https://longbridge.com/en/news/296343171.md)
- [Reformed pharmaceutical regulation across India’s drug landscape](https://longbridge.com/en/news/296321423.md)
- [Bashing AI data centers makes its way into brand marketing with new Jason Kelce ad](https://longbridge.com/en/news/296278546.md)
- [Immunology specialist Khartis Therapeutics emerges from stealth with $95m](https://longbridge.com/en/news/295919132.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**